inherit
primari
immunodefici
diseas
pid
known
exist
gene
respons
mani
diseas
also
identifi
recent
advanc
diagnost
procedur
enabl
identifi
earlier
appropri
treat
number
approach
avail
identifi
mutat
direct
sequenc
remain
gold
standard
approach
identifi
exact
genet
chang
substanti
precis
suggest
sensit
econom
approach
mutat
detect
could
direct
sequenc
cdna
follow
confirmatori
sequenc
correspond
exon
screen
techniqu
singlestrand
conform
polymorph
sscp
heteroduplex
analysi
ha
denatur
gradient
gel
electrophoresi
dgge
denatur
highperform
liquid
chromatographi
dhplc
proven
use
inher
advantag
disadvantag
discuss
advantag
disadvantag
also
discuss
potenti
futur
sequenc
technolog
pyrosequenc
combinatori
sequencingbyhybrid
multiplex
polymeras
coloni
poloni
resequenc
array
tool
futur
mutat
detect
addit
briefli
discuss
sever
highthroughput
snp
detect
technolog
human
immun
system
respons
protect
host
infect
caus
bacteria
virus
fungi
parasit
protect
achiev
nonspecif
innat
specif
adapt
immun
respons
defect
either
compon
immun
system
lead
diseas
may
ultim
result
death
particularli
appar
primari
immunodefici
diseas
pid
caus
congenit
defect
immun
system
bonilla
geha
sever
diagnost
criteria
exist
determin
individu
suffer
pid
conley
et
al
hallmark
sign
present
recurr
infect
pathogen
host
normal
display
effect
resist
pneumocysti
carinii
laboratorybas
diagnosi
pid
involv
enumer
leukocyt
cell
number
evalu
function
respons
approach
use
classifi
type
pid
classif
definit
establish
without
determin
genotyp
sinc
gene
respons
mani
pid
known
genet
type
possibl
notarangelo
et
al
howev
larg
number
differ
molecular
techniqu
use
diagnos
pid
often
difficult
decid
appropri
use
suggest
mutat
analysi
could
commenc
direct
sequenc
cdna
gene
interest
confirm
presenc
mutat
correspond
genom
exon
discuss
commonli
practic
wellestablish
techniqu
use
screen
diseas
caus
mutat
includ
singlestrand
conform
polymorph
sscp
heteroduplex
analysi
ha
denatur
gradient
gel
electrophoresi
dgge
denatur
highperform
liquid
chromatographi
dhplc
advantag
disadvantag
approach
discuss
potenti
novel
sequenc
technolog
singlenucleotid
polymorph
snp
identif
also
discuss
diagnosi
individu
frequent
recurr
infect
indic
presenc
pid
normal
involv
assess
blood
leukocyt
profil
function
analysi
differenti
count
determin
major
leukocyt
popul
present
within
normal
refer
rang
addit
combin
flow
cytometri
illoh
ratio
individu
cell
popul
also
determin
exampl
surfac
express
ligand
reduc
absent
xlink
hyperimmunoglobulin
hyperigm
syndrom
mim
one
caveat
relat
use
flow
cytometri
note
cell
surfac
protein
mutat
may
still
express
surfac
cell
lead
conclus
protein
mutat
amino
acid
substitut
may
present
cytoplasm
domain
protein
render
receptor
nonfunct
although
mutat
may
also
exist
extracellular
domain
receptor
flow
cytometri
unabl
distinguish
differ
diagnosi
coupl
cell
specif
function
studi
exampl
lack
vitro
igg
product
follow
crosslink
patient
suspect
xlink
hyperigm
syndrom
western
blot
also
use
determin
presenc
absenc
protein
thu
aid
diagnosi
pid
level
protein
allow
variant
diseas
identifi
exampl
xlink
chronic
granulomat
diseas
cgd
mim
exist
three
variant
form
mutat
gene
cybb
encod
protein
phox
lead
protein
present
yet
nonfunct
reduc
absent
patient
neutrophil
cross
et
al
roo
et
al
sever
combin
immunodefici
scid
present
individu
leukocyt
popul
absent
significantli
reduc
exampl
signific
reduct
circul
tlymphocyt
abnorm
lymphocyt
prolifer
abnorm
faci
absenc
thymic
shadow
indic
digeorg
syndrom
mim
wilson
et
al
individu
recurr
bacteri
infect
also
serum
immunoglobulin
complement
level
routin
measur
either
nephelometri
enzymelink
immunosorb
assay
elisa
ferrant
et
al
assess
cellular
function
respons
also
provid
addit
inform
statu
individu
leukocyt
popul
exampl
prolifer
tand
blymphocyt
assess
respons
mitogen
antigen
stimuli
amedei
et
al
neutrophil
abil
migrat
zicha
et
al
produc
reactiv
oxygen
speci
jirapongsananuruk
et
al
kill
bacteria
fungi
assess
vitro
wolach
et
al
investig
provid
physician
abil
predict
diseas
turn
gene
examin
signific
progress
made
defin
molecular
caus
mani
currentlyclassifi
pid
numer
diseas
specif
databas
publicli
avail
tabl
et
al
resourc
relat
individu
group
diseas
includ
type
spectrum
mutat
supplementari
tabl
avail
onlin
http
wwwintersciencewileycom
relev
research
public
detail
particular
molecular
approach
use
diagnos
particular
diseas
also
highlight
therefor
consult
start
point
analysi
gene
interest
screen
techniqu
use
rapidli
identifi
defect
gene
investig
facilit
diagnost
process
suggest
mutat
detect
diseas
commenc
sequenc
cdna
gene
investig
follow
sequenc
correspond
genom
exon
fig
sinc
mani
screen
techniqu
display
sensit
mutat
detect
strategi
divid
two
categori
identifi
specif
previous
character
sequenc
variat
detect
uncharacter
sequenc
variat
exampl
former
detect
specif
mutat
gene
mim
regul
serum
level
human
mannos
bind
lectin
protein
masp
level
protein
modul
three
known
sequenc
variat
cluster
exon
turner
hamva
individu
low
absent
masp
protein
thu
screen
sequenc
variat
howev
gene
search
previous
character
sequenc
variat
use
mutat
hotspot
uncommon
exampl
xlink
cgd
predominantli
caus
mutat
protein
phox
plot
locat
amino
acid
substitut
vs
locat
protein
amino
acid
chang
scatter
along
entir
length
protein
discern
mutat
hotspot
fig
common
mani
diseas
make
mutationspecif
detect
technolog
unsuit
uncommon
individu
possess
uniqu
mutat
laboratori
must
therefor
interrog
entir
gene
interest
identifi
locat
natur
diseasecaus
mutat
sinc
averag
size
human
gene
kb
number
exonsgen
nine
sakharkar
et
al
mutat
scan
techniqu
sscp
ha
dhplc
dgge
temperatur
gradient
gel
electrophoresi
tgge
conformationsensit
gradient
electrophoresi
csge
use
rapidli
identifi
product
mutat
may
exist
subsequ
sequenc
identifi
precis
genet
chang
present
diseasecaus
mutat
caus
microles
missensenonsens
splice
regulatori
small
delet
insert
remaind
caus
gross
lesion
repeat
variat
gross
insertionsdupl
complex
rearrang
gross
delet
stenson
et
al
supplementari
tabl
sequenc
variat
identifi
use
techniqu
outlin
screen
techniqu
requir
gene
interest
amplifi
pcr
individu
exon
amplifi
either
one
product
individu
exon
larg
smaller
overlap
fragment
subject
mutat
screen
theori
behind
techniqu
advantag
disadvantag
detect
mutat
discuss
summar
tabl
nearli
pid
mutat
detect
studi
commenc
interrog
genom
dna
use
screen
techniqu
suggest
direct
sequenc
cdna
effici
approach
detect
pathogen
mutat
sinc
cell
blood
easili
obtain
analysi
facilit
figur
flowchart
outlin
current
approach
diagnosi
xlink
chronic
granulomat
diseas
initi
diagnosi
made
assess
biolog
cellular
function
product
assess
superoxid
product
provid
rapid
guid
cgd
diagnosi
xlink
diseas
femal
display
mosaic
phenotyp
seen
nitroblu
tetrazolium
test
presenceabs
protein
use
help
subclassifi
precis
variant
cgd
three
variant
exist
xlink
form
total
rna
individu
well
famili
member
isol
convert
cdna
cybb
gene
use
cdna
templat
product
directli
sequenc
mutat
found
variant
need
assess
autosom
form
cgd
mutat
analysi
perform
like
gene
involv
mutat
genom
level
correspond
exon
sequenc
mutationspolymorph
screen
known
mutat
mutat
report
previous
need
exclud
novel
polymorph
either
restrict
enzym
digest
allel
pcr
novel
mutat
submit
relev
databas
cybb
base
cybb
gene
process
rna
isol
cost
term
time
reagent
one
main
limit
factor
associ
sequenc
multiexon
gene
without
prior
screen
approach
exampl
cybb
gene
consist
exon
royerpokora
et
al
requir
minimum
primer
amplif
exon
must
sequenc
direct
confirm
sequenc
thu
least
sequenc
reaction
need
screen
entir
gene
nomin
cost
sequenc
reaction
us
total
cost
sequenc
alon
us
routin
prepar
cdna
patient
cell
use
overlap
pair
primer
amplifi
sequenc
entir
cdna
fig
abl
amplifi
entir
cybb
cdna
use
five
pair
primer
reduc
cost
mutat
observ
correspond
exon
sequenc
confirm
presenc
genom
level
fig
disadvantag
approach
depend
upon
presenc
suitabl
mrna
patient
sampl
mutat
reduc
mrna
product
andor
stabil
therebi
reduc
effect
approach
howev
given
sensit
rtpcr
even
small
amount
mrna
readili
convert
cdna
mrna
exist
dna
would
balogh
et
al
cotton
inexpens
fragment
size
limit
factor
hayashi
andyandel
nataraj
et
al
use
commonli
avail
reagent
equip
exact
natur
nucleotid
chang
unknown
orita
et
al
et
al
high
throughput
need
interrog
directli
also
pathogen
mutat
found
intron
sequenc
would
miss
analyz
cdna
alon
howev
rare
vast
major
pathogen
mutat
found
code
sequenc
sequenc
technolog
also
improv
past
decad
capillari
machin
allow
high
throughput
screen
patient
sampl
approach
enhanc
throughput
given
mani
pid
rare
workload
clinic
diagnost
laboratori
overli
excess
limit
use
definit
approach
histor
sscp
commonli
use
screen
techniqu
identifi
mutat
sinc
first
report
orita
et
al
includ
mutat
caus
pid
exampl
pid
sscp
use
includ
bruton
tyrosin
kinas
mim
conley
et
al
vorechovski
et
al
chronic
granulomat
diseas
mim
aoshima
et
al
patino
et
al
wiskottaldrich
syndrom
mim
derri
et
al
kondoh
et
al
sscp
involv
pcr
amplif
gene
interest
denatur
use
heat
formamid
produc
singlestrand
dna
ssdna
fragment
separ
nondenatur
electrophoresi
electrophoresi
ssdna
fold
nucleotid
sequencedepend
conform
shape
determin
rate
mobil
gel
base
chang
alter
physic
conform
dna
suffici
detect
mobil
differ
humphri
et
al
sscp
use
due
low
cost
use
common
reagent
equip
suitabl
high
throughput
analysi
reason
sensit
sscp
also
perform
absenc
radioact
label
cotton
howev
sinc
small
amount
dna
load
highli
sensit
detect
method
need
radioact
marker
use
sensit
either
ethidium
bromid
silver
stain
sunnuck
et
al
fluoresc
dye
sybr
green
carlsbad
ca
wwwinvitrogencom
becom
popular
altern
law
et
al
major
disadvantag
sscp
lack
sensit
rang
liu
et
al
match
capillari
base
electrophoresi
mogensen
et
al
falseneg
result
drastic
effect
patient
treatment
regim
buckley
size
pcr
product
directli
affect
sensit
assay
exampl
mutat
present
bglobin
rhodopsin
gene
identifi
pcr
product
bp
sheffield
et
al
yet
sensit
fell
product
shorten
bp
increas
bp
choic
gel
matrix
electrophoret
condit
buffer
composit
gc
content
dna
concentr
locat
sequenc
variat
humphri
et
al
liechtigallati
et
al
nataraj
et
al
concentr
glycerol
constanc
temperatur
electrophoresi
balogh
et
al
nataraj
et
al
affect
sensit
gener
mutat
detect
fragment
bp
vari
optim
condit
detect
rate
fall
fragment
longer
bp
shorter
bp
hayashi
yandel
product
larger
bp
first
digest
use
suitabl
restrict
enzym
subject
sscp
analysi
addit
step
add
cost
complex
assay
addit
choic
restrict
enzym
use
affect
sensit
assay
exampl
digest
bglii
improv
detect
two
mutant
digest
fragment
hinfi
hayashi
yandel
lee
et
al
note
howev
effect
mutat
specif
gener
two
restrict
enzym
one
reason
variabl
sensit
associ
sscp
due
empir
optim
assay
condit
possibl
predict
electrophoret
pattern
expect
sscp
analysi
balogh
et
al
poorli
standard
condit
lead
difficult
interpret
mobil
pattern
cotton
give
rise
possibl
falseneg
posit
result
achiev
optim
sensit
gene
exon
larger
bp
need
amplifi
set
overlap
primer
produc
product
suitabl
size
ha
depend
conform
duplex
dna
resolv
nativ
polyacrylamid
gel
pcramplifi
dna
consist
either
two
complementari
strand
strand
singlebas
pair
mismatch
mismatch
dna
form
heteroduplex
nagamin
et
al
retard
electrophoret
mobil
compar
homoduplex
fragment
alter
mobil
sequenc
nucleotid
mismatch
principl
factor
influenc
separ
heteroduplex
homoduplex
exampl
g
gc
c
mismatch
easili
identifi
mismatch
ha
technic
simpl
cheap
perform
henderson
et
al
ha
report
detect
rate
similar
sscp
rossetti
et
al
requir
signific
optim
mani
case
pair
sscp
increas
detect
sensit
although
lead
increas
workload
per
sampl
factor
affect
ha
sensit
includ
electrophoret
condit
type
base
substitut
base
sequenc
gc
content
fragment
fragment
size
optim
size
bp
morelli
et
al
nollau
wagen
denatur
highperform
liquid
chromatographi
dhplc
dhplc
involv
subject
pcr
product
ionpair
reversephas
liquid
chromatographi
column
contain
alkyl
nonpor
particl
huber
et
al
oefner
underhil
use
gradient
acetonitril
partial
heat
denatur
heteroduplex
display
reduc
column
retent
time
compar
wildtyp
homoduplex
xiao
oefner
dhplc
show
signific
drop
sensit
size
rang
bp
liu
et
al
odonovan
et
al
also
display
excel
specif
exampl
mutat
identifi
use
dhplc
analyz
factor
ix
blood
coagul
mim
neurofibromatosi
type
gene
mim
odonovan
et
al
contrast
mutat
detect
use
sscp
liu
et
al
similarli
sscp
fail
detect
mutat
associ
multipl
endocrin
neoplasia
type
mim
detect
dhplc
park
et
al
softwar
avail
predict
appropri
condit
temperatur
acetonitril
concentr
given
nucleotid
sequenc
order
detect
heteroduplex
disadvantag
dhplc
requir
special
piec
equip
molecular
laboratori
equip
requir
perform
sscp
ha
dhplc
requir
dedic
piec
equip
also
difficult
identifi
heterozygot
unless
sampl
spike
known
control
techniqu
describ
exact
natur
locat
nucleotid
chang
also
unknown
conformationsensit
denatur
temperaturegradi
gel
electrophoresi
csge
dgge
tgge
csge
dgge
tgge
involv
electrophoresi
pcr
amplifi
doublestrand
dna
gradient
denatur
urea
formamid
dgge
temperatur
tgge
constant
concentr
denatur
without
gradient
csge
heteroduplex
homoduplex
separ
accord
differ
melt
behavior
caus
differ
sequenc
mismatch
present
area
sequenc
variat
dgge
concentr
denatur
agent
tgge
temperatur
buffer
increas
mobil
dna
reduc
dna
begin
denatur
csge
develop
ha
use
modifi
polyacrylamid
gel
ganguli
et
al
differenti
homoduplex
heteroduplex
simpl
protocol
use
routin
laboratori
equip
use
pcr
product
without
manipul
main
incent
use
techniqu
inclus
fluoresc
tag
increas
speed
reproduc
enhanc
resolv
power
scan
method
disadvantag
includ
requir
access
autom
dna
sequenc
cost
synthes
fluoresc
primer
need
special
skill
data
analysi
manag
ganguli
size
mismatch
sequenc
context
mismatch
affect
sensit
csge
csge
also
less
sensit
mismatch
gcrich
area
atrich
area
ganguli
main
disadvantag
dgge
prepar
denatur
gradient
gel
consist
reproduc
lead
variabl
balogh
et
al
sensit
also
issu
report
morelli
et
al
sensit
csge
reduc
mismatch
locat
within
bp
end
tgge
requir
use
denatur
agent
requir
less
sampl
handl
greater
reproduc
cost
effect
balogh
et
al
techniqu
examin
chang
nucleotid
composit
variat
mobil
maximum
fragment
size
dgge
tgge
csge
approxim
bp
balogh
et
al
fluoresc
csge
bp
ganguli
way
definit
identifi
individu
harbor
genet
mutat
sequenc
entir
gene
term
sequenc
sever
method
exist
howev
well
establish
dideoxi
chain
termin
method
sanger
et
al
pyrosequenc
ronaghi
et
al
discuss
addit
futur
prospect
use
sequenc
hybrid
multiplex
polymeras
coloni
poloni
sequenc
oligonucleotid
array
also
discuss
sequenc
dideoxi
chain
termin
sanger
et
al
base
dna
synthesi
occur
presenc
mixtur
deoxyand
dideoxynucleotid
ddntp
ddntp
randomli
incorpor
grow
strand
dna
caus
amplifi
product
vari
length
termin
prematur
termin
fragment
analyz
gel
electrophoresi
read
manual
ddntp
link
fluorochrom
autom
via
capillari
electrophoresi
ce
dideoxi
sequenc
use
sequenc
sever
differ
bacteri
archaeal
eukaryot
genom
wwwncbinlmnihgov
wwwtigrorg
human
genom
lander
et
al
venter
et
al
sequenc
true
method
identifi
uncharacter
nucleotid
chang
allow
consequ
chang
determin
prematur
stop
codon
missens
silent
mutat
xlink
diseas
carrier
statu
femal
famili
member
import
consider
particularli
provid
genet
counsel
introduct
improv
dye
chemistri
detect
carrier
statu
facilit
cost
sequenc
issu
becom
less
improv
fluoresc
technolog
smaller
amount
label
use
effici
detect
sampl
sequenc
sequenc
also
pair
screen
techniqu
howev
approach
applic
laboratori
requir
equip
method
gener
falseposit
sequenc
variat
introduc
pcr
amplif
target
possibl
howev
polymeras
proofread
abil
inher
low
error
rate
avail
addit
mutat
pcr
product
confirm
use
altern
techniqu
restrict
enzym
digest
possibl
allelespecif
pcr
pyrosequenc
techniqu
detect
releas
pyrophosph
ppi
dna
synthesi
ronaghi
et
al
seri
four
enzymat
reaction
link
releas
visibl
light
whose
gener
proport
number
incorpor
nucleotid
cascad
start
nucleic
acid
polymer
reaction
inorgan
ppi
releas
result
nucleotid
incorpor
dna
polymeras
releas
ppi
convert
atp
ultim
lead
releas
light
sinc
nucleotid
ad
stepwis
fashion
order
known
sequenc
templat
determin
technolog
recent
use
success
sequenc
bacteri
genom
hr
marguli
et
al
well
detect
snp
mannosebind
lectin
roo
et
al
also
use
microbi
type
resequenc
tag
sequenc
analysi
dna
sequenc
difficult
secondari
structur
ronaghi
major
disadvantag
pyrosequenc
limit
read
length
ahmadian
et
al
typic
use
mutat
detect
garcia
et
al
addit
perform
four
enzym
crucial
accuraci
dna
sequenc
technolog
enzym
activ
lost
time
sampl
dilut
nucleotid
subsequ
ad
also
reduc
enzym
activ
neg
impact
read
length
ronaghi
resequenc
sequenc
dna
whose
sequenc
previous
annot
resequenc
achiev
standard
sequenc
technolog
recent
new
technolog
appli
largescal
resequenc
gene
genom
one
approach
combinatori
sequencingbyhybrid
csbh
cowi
et
al
drmanac
et
al
csbh
univers
probe
attach
glass
slide
fluorophorelabel
probe
free
solut
unlabel
pcramplifi
target
dna
mix
dna
ligas
label
probe
solut
allow
hybrid
slideattach
probe
probe
hybrid
target
dna
contigu
complementari
posit
coval
join
dna
ligas
creat
one
longlabel
probe
attach
solid
surfac
combinatori
process
gener
possibl
probe
complementari
target
standard
array
reader
score
fluoresc
signal
array
posit
softwar
gener
sequenc
readout
templat
pcr
product
approach
avail
callida
genom
sunnyval
ca
wwwcallidagenomicscom
approach
use
screen
mutat
apc
gene
mim
caus
autosom
domin
form
colorect
cancer
cowi
et
al
total
clinic
diagnos
individu
famili
adenomat
polyposi
screen
maxim
read
length
kb
base
sequenc
accuraci
approach
also
use
interrog
neurofibromatosi
type
gene
mim
schirinzi
et
al
total
patient
examin
readabl
accuraci
found
respect
reduct
uncal
base
reduc
background
achiev
dual
label
use
base
substitut
insert
small
delet
confirm
patient
oligonucleotid
resequenc
array
reli
hybrid
fragment
endlabel
dna
set
tile
overlap
oligonucleotid
probe
base
interrog
four
probe
one
repres
refer
sequenc
three
vari
central
base
one
three
nucleotid
mockler
et
al
probe
correspond
sens
antisens
strand
synthes
array
signal
intens
probe
analyz
give
homozyg
heterozyg
base
call
chee
et
al
warrington
et
al
mismatch
middl
base
reduc
prevent
bind
label
target
thu
result
reduc
hybrid
signal
present
custom
resequenc
array
avail
affymetrix
santa
clara
ca
wwwafftymetrixcom
use
system
hacia
et
al
screen
possibl
mutat
ataxiatelangiectasia
mim
gene
use
approach
distinct
heterozyg
distinct
homozyg
sequenc
variant
detect
accur
five
falseposit
call
identifi
karaman
et
al
extend
studi
use
oligonucleotid
array
determin
hybrid
properti
probe
complementari
small
insert
delet
probe
complementari
two
base
substitut
display
highest
averag
specif
follow
complementari
singlebas
substitut
singlebas
delet
singlebas
insert
karaman
et
al
resequenc
array
also
appli
detect
sequenc
variat
multipl
autosom
recess
retin
diseas
mandal
et
al
cancerassoci
gene
teng
et
al
mandal
et
al
sequenc
gene
exon
associ
autosom
recess
retin
pigmentosa
mim
sequenc
determin
greater
accuraci
reproduc
similarli
teng
et
al
found
homozyg
chang
heterozyg
loci
identifi
correctli
wong
et
al
use
resequenc
array
interrog
sever
acut
respiratori
syndrom
sar
viru
genom
method
highli
reproduc
accur
capabl
identifi
known
novel
variant
sar
similarli
zwick
et
al
resequenc
multipl
isol
bacillu
anthraci
accuraci
major
advantag
arraybas
resequenc
prior
knowledg
variat
site
need
comparison
made
directli
refer
genom
sequenc
thu
singl
analysi
allow
snp
identifi
mockler
et
al
one
disadvantag
resequenc
technolog
relat
composit
probe
probe
high
content
hacia
et
al
gc
content
mandal
et
al
zwick
et
al
affect
hybrid
intens
prevent
base
effici
detect
problem
exist
even
organ
low
content
b
anthraci
zwick
et
al
technolog
also
depend
avail
finish
qualiti
refer
sequenc
also
sinc
resequenc
array
compar
new
sequenc
refer
sequenc
use
identifi
novel
sequenc
sequenc
rearrang
may
occur
experiment
sampl
mention
diseas
associ
set
wellcharacter
mutat
masp
protein
turner
hamva
case
assay
base
highthroughput
snp
detect
use
exampl
two
techniqu
includ
singlenucleotid
extens
sne
oligonucleotid
ligat
assay
ola
snplex
sne
primer
design
anneal
immedi
polymorph
site
interest
dna
polymeras
use
extend
primer
singl
label
nucleotid
complementari
nucleotid
variant
site
label
product
detect
ce
approach
allow
highlyspecif
detect
snp
use
numer
report
murphi
et
al
snplex
platform
modif
ola
produc
appli
biosystem
foster
citi
ca
wwwappliedbiosystemscom
oligonucleotid
ligationpcr
ce
use
analyz
biallel
snp
genotyp
approach
well
suit
snp
genotyp
throughput
cost
effici
essenti
snplex
allelespecif
oligonucleotid
aso
probe
locu
specif
oligonucleotid
lso
probe
hybrid
target
sequenc
two
oligonucleotid
bind
perfect
match
sequenc
snp
site
time
univers
linker
ligat
distal
termini
probe
linker
univers
primer
bind
sequenc
well
sequenc
complementari
aso
lso
probe
uniqu
code
place
end
aso
facilit
identif
target
sequenc
probe
design
function
hybrid
condit
unlig
probe
linker
genom
dna
remov
enzymat
digest
purifi
ligat
product
amplifi
use
one
set
univers
primer
one
biotinyl
biotinyl
amplicon
captur
use
streptavidin
fluorescentlylabel
univers
probe
bind
uniqu
termini
separ
ce
tobler
et
al
use
snplex
genotyp
system
test
snp
genom
control
dna
sampl
well
snp
individu
approach
demonstr
overal
call
rate
precis
concord
taqman
assay
respect
sever
novel
highthroughput
multiplex
sequenc
technolog
develop
aim
sequenc
genom
sequencingbysynthesi
sb
pioneer
solexa
hayward
ca
wwwsolexacom
use
four
fluorescentlylabel
modifi
nucleotid
sequenc
million
fragment
dna
cdna
parallel
one
base
time
modifi
nucleotid
li
et
al
possess
revers
termin
properti
ruparel
et
al
allow
sequenc
cycl
occur
simultan
presenc
four
nucleotid
anoth
highthroughput
sequenc
technolog
poloni
sequenc
amplifi
templat
molecul
parallel
independ
shendur
et
al
zhang
et
al
although
still
techniqu
requir
optim
shendur
et
al
abl
resequ
million
base
e
coli
strain
median
raw
accuraci
day
use
approach
zhang
et
al
perform
longrang
multilocu
haplotyp
span
five
snp
span
mb
chromosom
diagnosi
pid
complement
combin
cellular
immunochem
molecularbas
approach
cellularbas
assay
enabl
assess
phenotyp
manifest
molecular
approach
provid
definit
result
origin
immunodefici
fortun
recent
mutat
scan
techniqu
facilit
molecular
diagnosi
pid
nevertheless
need
awar
approach
discuss
apart
dhplc
suffer
lack
sensit
lead
gener
fals
neg
result
limit
dhplc
depend
upon
use
dna
sequenc
identifi
exact
genet
chang
dna
sequenc
still
techniqu
provid
definit
answer
variat
gene
sequenc
may
may
result
genet
diseas
howev
sensit
limit
mutat
detect
method
one
key
advantag
use
direct
sequenc
amplif
individu
exon
gene
follow
dna
sequenc
make
approach
cost
effect
result
altern
strategi
reduc
need
entir
sequenc
gene
develop
discuss
approach
aim
reduc
total
number
sampl
need
sequenc
analyz
cdna
fragment
confirm
chang
individu
genom
exon
technolog
improv
cost
associ
sequenc
reduc
feasibl
laboratori
sequenc
gene
associ
pid
one
event
therebi
identifi
gene
potenti
interest
thank
professor
grant
sutherland
critic
read
manuscript
